Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by Karolinska Institutet
Sponsor:
Information provided by (Responsible Party):
Ronald van Vollenhoven, prof., Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT01491815
First received: December 8, 2011
Last updated: December 1, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)